600056 中國醫藥
按盤價 
10.720 -0.200 (-1.832%) | 2025/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 17,075,860 | -6.71% | 34,148,360 | 38,824,431 | 37,592,650 | 36,234,415 | |
| 減：營業總成本 | 16,438,280 | -6.80% | 32,983,445 | 37,501,895 | 36,137,940 | 34,480,964 | |
| 其中:營業成本 | 15,294,246 | -6.22% | 30,489,594 | 34,440,814 | 32,845,786 | 31,018,239 | |
| 財務費用 | (9,775) | -110.07% | 195,924 | 112,038 | 138,317 | 221,691 | |
| 資產減值損失 | 266 | -78.17% | (175,326) | (13,539) | (280,660) | (575,297) | |
| 公允價值變動收益 | 5,891 | -631.44% | 127,467 | 985 | 1,922 | (2,135) | |
| 投資收益 | 9,457 | 324.46% | (65,017) | (15,792) | 51,001 | 43,657 | |
| 其中：對聯營企業和合營企業的投資收益 | 28,746 | 24.18% | 18,736 | 77,043 | 93,219 | 113,900 | |
| 營業利潤 | 524,870 | -16.59% | 931,568 | 1,672,334 | 1,199,698 | 937,135 | |
| 利潤總額 | 520,722 | -16.90% | 953,189 | 1,640,556 | 1,196,127 | 940,106 | |
| 減：所得稅費用 | 145,395 | -3.93% | 266,565 | 398,435 | 307,699 | 225,830 | |
| 淨利潤 | 375,327 | -21.03% | 686,624 | 1,242,120 | 888,428 | 714,276 | |
| 減：非控股權益 | 81,368 | -34.65% | 151,156 | 194,081 | 152,827 | 67,219 | |
| 股東淨利潤 | 293,959 | -16.19% | 535,468 | 1,048,039 | 735,601 | 647,057 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.197 | -16.20% | 0.358 | 0.701 | 0.492 | 0.433 | |
| 每股派息 (元) * | 0.020 | -9.57% | 0.107 | 0.210 | 0.148 | 0.182 | |
| 每股淨資產 (元) * | 7.837 | 1.33% | 7.902 | 7.728 | 7.230 | -- | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 03/09/2025 15:13 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
